Table 1 Statistical analysis of LASP-1 expression in 83 breast cancer samples (in-CA), 25 ductal carcinomas in situ (DCIS) and 18 fibroadenomas (FIBRO). IRS: immune reactive score; n.s.: not significant
| Â | LASP-1 + | LASP-1 - | IRS mean | IRS STDV | IRS Median | p-values (Fisher's exact) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | n | % | n | % | Â | Â | Â | Â | Â | Â |
FIBRO | 4 | 22.2 | 14 | 77.8 | 3.11 | 2.22 | 3 | 0.7315 n.s. | Â | 0.0176* |
DCIS | 8 | 32 | 17 | 68 | 3.48 | 2.80 | 3 | 0.7315 n.s. | 0.066 n.s. | 0.0176* |
in-CA | 46 | 55.4 | 37 | 44.6 | 5.75 | 3.73 | 8 | Â | 0.066 n.s. | 0.0176* |